Portfolio (Quarterly)
Guide ↗
PSP Research LLC
· CIK 0002106939| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NRIX | NURIX THERAPEUTICS INC | Healthcare | 25,000.0 | $606K | 0.32% | -4K | -12.9% | $24.26 | +8.0% |
| 2 | RARE | ULTRAGENYX PHARMACEUTICAL IN | Healthcare | 17,000.0 | $568K | 0.30% | -5K | -23.1% | $33.39 | -23.3% |
| 3 | GLUE | MONTE ROSA THERAPEUTICS INC | Healthcare | 23,000.0 | $557K | 0.30% | -5K | -17.9% | $24.20 | -44.7% |
| 4 | TGTX | TG THERAPEUTICS INC | Healthcare | 10,000.0 | $549K | 0.29% | -3K | -23.1% | $54.94 | -1.8% |
| 5 | HALO | HALOZYME THERAPEUTICS INC | Healthcare | 7,000.0 | $548K | 0.29% | -1K | -12.8% | $78.27 | +34.6% |
| 6 | PHVS | PHARVARIS N V | Healthcare | 15,000.0 | $519K | 0.28% | -5K | -25.0% | $34.58 | +2.1% |
| 7 | NBIX | NEUROCRINE BIOSCIENCES INC | Healthcare | 3,000.0 | $506K | 0.27% | -848.0 | -22.0% | $168.53 | -8.6% |
| 8 | IMVT | IMMUNOVANT INC | Healthcare | 13,000.0 | $501K | 0.27% | -6K | -32.3% | $38.53 | +6.9% |
| 9 | DFTX | DEFINIUM THERAPEUTICS INC | Healthcare | 10,000.0 | $470K | 0.25% | -25K | -71.3% | $47.04 | -12.9% |
| 10 | KYMR | KYMERA THERAPEUTICS INC | Healthcare | 4,000.0 | $459K | 0.24% | -2K | -36.5% | $114.67 | +3.0% |
| 11 | EXEL | EXELIXIS INC | Healthcare | 8,000.0 | $435K | 0.23% | -4K | -33.0% | $54.41 | +0.1% |
| 12 | — | NEWAMSTERDAM PHARMA COMPANY | — | 12,000.0 | $407K | 0.22% | -3K | -20.0% | $33.89 | — |
| 13 | VKTX | VIKING THERAPEUTICS INC | Healthcare | 10,000.0 | $390K | 0.21% | -5K | -33.3% | $39.01 | -17.6% |
| 14 | IMNM | IMMUNOME INC | Healthcare | 18,000.0 | $381K | 0.20% | -2K | -10.0% | $21.19 | +30.1% |
| 15 | HRMY | HARMONY BIOSCIENCES HLDGS IN | Healthcare | 10,000.0 | $364K | 0.19% | -4K | -30.0% | $36.41 | +7.7% |
| 16 | SYRE | SPYRE THERAPEUTICS INC | Healthcare | 4,000.0 | $355K | 0.19% | -1K | -22.5% | $88.78 | +1.8% |
| 17 | NTLA | INTELLIA THERAPEUTICS INC | Healthcare | 20,000.0 | $338K | 0.18% | -7K | -25.6% | $16.92 | -23.9% |
| 18 | — | KINIKSA PHARMACEUTICALS INTL | — | 5,000.0 | $320K | 0.17% | -4K | -44.4% | $63.95 | — |
| 19 | TNGX | TANGO THERAPEUTICS INC | Healthcare | 10,000.0 | $313K | 0.17% | -4K | -30.6% | $31.26 | -25.3% |
| 20 | ARDX | ARDELYX INC | Healthcare | 60,000.0 | $306K | 0.16% | -20K | -25.0% | $5.10 | -25.3% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%